Gilead's tie up with generic cos may not address HIV challenge – Times of India
US pharma giant Gilead’s partnership with domestic generic manufacturers, aimed at enhancing…
Dr Reddy's, Hetero ink royalty-free voluntary licencing pacts with Gilead Sciences for HIV drug Lenacapavir – Times of India
Dr Reddy’s Laboratories HYDERABAD: Dr Reddy’s Laboratories and Hetero are among half…
New 'vaccine-like' HIV drug could cost just $40: researchers – Times of India
PARIS: A new 'vaccine-like' HIV drug that currently costs over $40,000 per…
